ONCT-534 recruiting
ONCT-534 Earns FDA Fast Track Designa... - Advanced Prostate...
ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC
Written by
Maxone73
To view profiles and participate in discussions please or .
5 Replies
•
Thanks. Their is still hope.
According to findings from preclinical studies, the agent has demonstrated activity in prostate cancer models with and without AR mutations.
Does not say what the basis for fast track is. Could it be more than mouse models?
it's for investigational drugs development, I thought it would happen after an incredibly promising start of phase 1, but it seems that the potential and the fact that it would be a lifesaver can be enough
from what I read they will sun a phase 1/2 instead of two separate phases
Good Luck, Good Health and Good Humor.
j-o-h-n Monday 10/30/2023 7:45 PM DST
My work of art............Little bastards having fun with my body.
Not what you're looking for?
You may also like...
FDA Fast Track Designation for 225Ac-FL-020 for mCRPCa
Another weapon, from Germany this time....ahhhh zee germanz! Actinium strikes again!
Phase 1 trial...
FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Is this superior to the LU177 now available?...
Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
FORT LAUDERDALE, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage...
Olaparib Combo Improves PFS/Responses in Metastatic CRPC - from ASCO GU2024
I am not sure, they always mix BTCA 1/2 and ATM, but maybe I can find the data for ATM only...but...
Clarity Pharmaceuticals gains FDA fast-track status for advanced prostate cancer 64Cu-SAR-bisPSMA imaging -hopefully soon also for treatment
As you know by now, I am following this technology pretty closely as it is very promising and their...